At the beginning of treatment, our results indicated that patients screened by FibroScan® [43] for steatosis and fibrosis exhibited significantly increased levels of CK18 [44] and mild to moderate elevations in hepatic liver enzymes [45]. The gene discussed is KRT18; the disease is fibrosis.